RETRACTED ARTICLE: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2

Table 1 Correlation between LATS2-AS1-001 expression and clinicopathological features of gastric cancer

Groups	n	LATS2-AS1-001 expression		P
Groups	n	High	Low	P
Gender				0.646
Male	267	81	186
Female	90	25	65
Age (year)				0.220
≥60	202	59	143
< 60	155	47	108
Tumor size				0.167
≥ 5	252	70	182
< 5	105	36	69
Borrmann’s types				0.394
Bor.I + II	30	11	19
Bor.III + IV	327	95	230
WHO’s histological types				0.448
Papillary adenocarcinoma	6	3	3
Tubular adenocarcinoma
Well differentiated	10	2	8
Moderately differentiated	80	25	55
Poorly differentiated	219	67	152
Signet ring cell adenocarcinoma	27	6	21
Mucinous adenocarcinoma	15	3	12
Lauren’s types				0.905
Intestinal	96	30	66
Diffuse	180	55	125
Mixed	81	21	60
Depth of invasion				0.568
T1 + 2	26	9	17
T3 + 4	331	97	234
Lymph node metastasis				0.282
N0	78	27	51
N1–3	279	79	200
Distant metastasis				0.968
M0	345	103	242
M1	12	3	9
TNM staging				0.032
I + II	100	38	62
III + IV	257	68	189

ISSN: 1475-2867